Product Transition Guide: Legacy Protein A Resins To Praesto™ AP+80

Cost efficiency is paramount in monoclonal antibody (mAb) production. Manufacturers and governments alike seek to lower pharmaceutical costs while upholding efficacy and regulatory standards. This guide explores strategies for reducing mAb production costs, focusing on transitioning to advanced chromatography resins.

It examines the complexities of adopting newer, more efficient resins, like Praesto™ AP+80, designed to boost productivity and cut costs without sacrificing quality. Detailed comparisons between Praesto™ AP+80 and a leading competitor are presented, covering dynamic binding capacity, pressure flow, and pH stability.

Learn about critical resin selection factors, including durability, scalability, and regulatory compliance, ensuring seamless integration into existing workflows. Other insights include practical guidance for optimizing mAb production processes.

Download the complete guide for valuable insights on transitioning to Praesto™ AP+80 and maximizing your production potential.